Philadelphia, PA, United States of America

Cameron Frank Abrams

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cameron Frank Abrams: Innovator in HIV-1 Treatment

Introduction

Cameron Frank Abrams is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of medical research, particularly in the treatment of HIV-1 infections. His innovative work has the potential to impact the lives of many individuals affected by this virus.

Latest Patents

Cameron Frank Abrams holds 1 patent for his invention titled "Compositions for promoting HIV-1 virolysis and methods using same." This patent includes compounds that are useful for treating or preventing an HIV-1 infection in mammals. In certain embodiments, the compounds cause cell-free virolysis of the HIV-1 virus. The invention also encompasses methods for causing virolysis of the virus using the described compounds, as well as methods for treating or preventing an HIV-1 infection in mammals in need of such treatment.

Career Highlights

Cameron is affiliated with Drexel University, where he conducts research and develops innovative solutions in the field of virology. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Cameron has collaborated with esteemed colleagues, including Irwin M Chaiken and Mark R Contarino. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.

Conclusion

Cameron Frank Abrams is a dedicated inventor whose work in HIV-1 treatment showcases his commitment to medical innovation. His contributions have the potential to make a significant difference in the lives of those affected by HIV-1.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…